Results 151 to 160 of about 25,067 (205)

Malignant reninoma with pulmonary metastasis and ATRX mutation treated with olaparib: a case report of specialized treatment. [PDF]

Front Immunol
Zi GR, Zhang DJ, He DL, Feng RL, Ke CX.
europepmc   +1 more source

Epacadostat and Olaparib Synergistically Inhibit the Growth of BRCA-Proficient Triple-Negative Breast Cancer by Suppressing the Expression of BRCA1 and RAD51. [PDF]

Molecules
Huang L, Yang Y, Duan D, Dai L, Zhai B, Qian B.   +5 more
europepmc   +1 more source

Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production. [PDF]

J Immunother Cancer
Murray CE, Ontiveros CO, Wentworth J, Blinkiewicz P, Leung B, Bai H, Spicer N, Holtz A, Tanner C, Balasubramanian A, Li W, Dray E, Zhao W, Curiel TJ.   +13 more
europepmc   +1 more source

Eprenetapopt in combination with carboplatin in high-grade ovarian and triple negative breast cancer cell lines with acquired resistance to olaparib. [PDF]

Front Oncol
Pineda B, Martinez-Pretel JJ, Sanchez-Serrano P, Boussios S, Rodrigo-Faus M, Pérez-Leal M, Obrador E, Perea J, Perez-Fidalgo JA.   +8 more
europepmc   +1 more source

Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer. [PDF]

Biomedicines
Correa Gonzalez B, Karthikeyan A, Moore LA, Bhaumik A, Sandoval E, Hardy M, McPherson JD, Li H, Parikh M, Dall'Era M, Gao AC, Lombard AP.   +11 more
europepmc   +1 more source

Case Report: Durable complete response to olaparib in a patient with BRCA2-driven metastatic gastric adenocarcinoma after failure of chemo-immunotherapy. [PDF]

Front Oncol
Karakaya G.
europepmc   +1 more source

BRCA mutation status and olaparib-related toxicity during maintenance therapy: a real-world retrospective cohort study. [PDF]

Front Oncol
Gao Y, Gai M, Zhang H, Li H.
europepmc   +1 more source

BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B). [PDF]

Breast Cancer
Sakai H, Kusumoto-Matsuo R, Hosonaga M, Nozawa K, Futamura M, Tanabe Y, Mukohara T, Shiraishi K, Toyama T, Yasojima H, Watanabe N, Sakai H, Iwasa T, Takeuchi N, Tada H, Sakai K, Chiba N, Takano T, Tsurutani J.   +18 more
europepmc   +1 more source

Durable complete remission of pulmonary metastases with bevacizumab plus olaparib maintenance therapy in homologous recombination-deficient gynecologic large-cell neuroendocrine carcinoma: A case report. [PDF]

Gynecol Oncol Rep
Iida Y, Saito Y, Shimazaki M, Ichikawa T, Irie T, Matsushima J, Iizuka M, Takakura S.   +7 more
europepmc   +1 more source